Humanoid Global Welcomes New Expertise with Dr. Ahad Armin
In an exciting development, Humanoid Global Holdings Corp. (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) is thrilled to announce the addition of Dr. Ahad Armin, PhD, P.Eng, to its Technical Advisory Committee. This strategic move signifies the company’s commitment to advancing in the humanoid robotics and embodied AI sectors, which are rapidly evolving fields. Dr. Armin’s extensive background in robotics, manufacturing, and mechanical simulation will undoubtedly enhance the company's trajectory.
Dr. Ahad Armin: A Wealth of Experience
Dr. Armin is currently a Lecturer at the School of Mechatronic Systems Engineering at Simon Fraser University. He brings over a decade of academic and industry expertise, particularly in areas such as finite element modeling and actuator development. His unique skill set encompasses dynamic systems and smart materials, making him a valuable asset to Humanoid Global.
Joshua Matettore, the CEO of Humanoid Global, expressed confidence in Dr. Armin’s abilities, stating, “His depth of experience across various domains in robotics positions him as an exceptional advisor. We are excited about the insights he will bring as we evaluate technical readiness and make strategic investment decisions.”
Advice Focus Areas
In his role, Dr. Armin will provide guidance on mechanical systems design, dynamic modeling, and applied robotics. This advisory position will support the company's ongoing technical due diligence processes and will aid in the development of their portfolio, which includes pioneering companies in the robotics field.
A Strong Academic and Industrial Foundation
Dr. Armin has previously contributed to the academic landscape at institutions like Red Deer Polytechnic and the University of Saskatchewan. His professional experience includes leading structural simulations at Canadian Mat Systems and building intelligent automation systems at the Centre for Innovation in Manufacturing. Additionally, he has worked on optimizing high-pressure components at Intelirain, thus reinforcing his well-rounded expertise in the sector.
Commitment to Innovation
Expressing enthusiasm for his new role, Dr. Armin stated, “Joining Humanoid Global’s Advisory Board aligns perfectly with my passion for innovative technologies in humanoid robotics. It’s an opportune moment to harness my knowledge in robotics and systems design to assist in nurturing a portfolio of impactful companies.”
Advisory Agreement and Equity Incentives
The advisory agreement is set to last twelve months, commencing soon. Notably, the Company has also granted Dr. Armin 50,000 incentive stock options and 50,000 restricted share units as part of their Stock Option and RSU Plans. These options can be exercised to buy shares at $0.61 each over the next five years, reflecting Humanoid Global’s commitment to incentivizing its advisors.
About Humanoid Global Holdings Corp.
Humanoid Global is not just a company; it’s a vision. As an investment issuer, it focuses on curating a portfolio of groundbreaking companies within the humanoid robotics and embodied AI sector. The Company’s strategic approach aims to provide liquidity and access to a diverse range of technologies. With a solid leadership team experienced in scaling transformative innovations worldwide, Humanoid Global is committed to forming long-term partnerships.
Those interested in understanding more about Humanoid Global’s mission and investment opportunities can reach out to Geoff Balderson, Chief Financial Officer, for further information.
For queries, you can contact Geoff Balderson at Humanoid Global Holdings Corp. at (604) 602-0001.
Frequently Asked Questions
What is the role of Dr. Ahad Armin at Humanoid Global?
Dr. Armin will serve on the Technical Advisory Committee, providing insights on mechanical design and robotics.
What experience does Dr. Armin bring to the company?
He brings over ten years of expertise in robotics, manufacturing, and dynamic modeling from both academic and industry perspectives.
How long is Dr. Armin's advisory agreement with Humanoid Global?
The advisory agreement is set for twelve months, starting shortly.
What incentives were provided to Dr. Armin?
Dr. Armin has received 50,000 stock options and 50,000 restricted share units as part of his agreement.
What is Humanoid Global's focus in the market?
Humanoid Global focuses on building a portfolio of pioneering companies in the humanoid robotics and embodied AI sectors.
